Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial
Yves Dauvilliers(Inserm), Giuseppe Plazzi(University of Modena and Reggio Emilia), М Г Полуэктов, Patricia Franco(Lyon 1 Université), Michel Lecendreux(Laboratoire National de Référence), Isabelle Lecomte(Bioprojet (France)), Christian Caussé(Bioprojet (France)), Jean Schwartz(Bioprojet (France)), Philippe Lehert(The University of Melbourne), J Lecomte(Bioprojet (France)), Gert Jan Lammers(Leiden University Medical Center)
Cited by 111
Related Papers
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Narcolepsy with cataplexy
|The Lancet|2007|716
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
|Nature Reviews Neurology|2019|634